Derive wants permission to knock on the US regulatory door. The onchain derivatives protocol published a Derive Improvement Proposal on October 12, 2026, asking token holders to let its foundation explore a fully regulated US trading venue.
The request is broad and the price tag is blank. The proposal sets no spending amount and no launch date.
What the proposal actually asks for
The proposal targets the Derive Foundation, the Cayman-based entity that oversees the protocol. If approved, the Foundation would gain authority to seek regulatory approvals in the US.
It could also form new entities or acquire existing ones to get there.
To pay for all this, the Foundation would be allowed to draw on limited treasury resources. That money would cover legal, compliance and technical work tied to the effort.
Nothing happens without a vote. Token holders must approve the proposal before the Foundation can act on any of it.
No initial product has been named. No financial commitment has been spelled out either. Any next steps will depend on how much clarity future US regulatory developments provide.
Two venues, one brand
The stated strategy is to keep Derive positioned as a leading DeFi market for participants outside the US, while the Foundation would assess whether a regulated US counterpart makes sense.
Derive already has a product lineup that would need to translate across that divide. The platform offers options, perpetual futures and spot trading, and it claims leadership in onchain options volume.
Perpetual futures are derivative contracts with no expiry date, letting traders hold leveraged positions indefinitely. Options give the right, but not the obligation, to buy or sell an asset at a set price.
Derive backs these products with risk management systems and support for multiple collateral types.
The DRV factor
The Foundation holds the protocol’s intellectual property and treasury assets, and those assets are weighted toward Derive’s native token, DRV.
DRV serves as the protocol’s governance and incentive token. It also sits at the center of revenue mechanisms that include buybacks and an insurance fund.
So when the proposal talks about spending treasury resources on lawyers and compliance staff, it is talking about a treasury heavy in DRV. Without a stated budget, holders are approving a direction rather than a dollar figure.
Why now
The proposal lands against a broader industry shift toward regulated derivatives frameworks in the US. Recent actions by the Commodity Futures Trading Commission, the agency that oversees most US derivatives markets, are part of that backdrop.
What this means
For DRV holders, the immediate stakes are about governance and treasury discipline. Voting yes grants the Foundation wide latitude with no fixed spending cap or deadline.
A regulated US venue could open Derive’s products to traders and institutions that cannot touch an offshore, permissionless protocol today.
If the treasury is DRV-weighted, sustained spending could add selling pressure or shrink the reserves that support buybacks and the insurance fund.
Watch three things from here. First, the vote itself, including turnout and any pushback over the lack of a budget. Second, whether the Foundation pursues a new entity or acquires an existing licensed one. Third, any follow-up disclosure on spending, since the size of the first check will say more about Derive’s conviction than the proposal does.
Disclosure: This article was edited by John Chen. For more information on how we create and review content, see our Editorial Policy.